10.12.22
Codex Beauty Labs, a Silicon Valley-based biotech skincare company, is now Codex Labs Corporation. The name change comes as the plant-based skincare company continues to increase its focus on skin conditions such as acne, eczema, psoriasis and rosacea.
Earlier this year, the company launched its third skincare line.
"We dropped the word 'beauty' from our name because we are more and more focused on OTC pharmacy skincare and skin analytics for data-driven skin health management. What began in 2021 with our Efficacy Panel presenting quantitative measurements of product performance in clinical efficacy trials, is a journey leading us to a skintech universe where it is possible to automate dermatological assessment of a skin condition and allow consumers to perform this analysis with their mobile," stated Dr. Barbara Paldus, CEO of Codex Labs.
Codex Labs also announced the launch of an alpha version of its DermScore Skin Analyzer for acne assessment. Consumers can submit a selfie to the www.codexlabscorp.com website where AI software will count comedones, inflammatory lesions, and post inflammatory hyperpigmentation (PIH) spots, as well as assess any existing melasma and freckles. While this software does not replace a trained medical professional, it will enable the consumer to start understanding their skin condition. As a first intervention, the consumer can then schedule a consultation by chat with a licensed esthetician for recommendations. Advice may include finding a licensed dermatologist for professional care and prescription topicals not yet provided by Codex Labs.
"This new AI assessment capability for skin conditions represents a first step towards a more quantified approach to personalized skin management, and a future array of at-home dermatology diagnostic tests," added Paldus. "We look
Earlier this year, the company launched its third skincare line.
"We dropped the word 'beauty' from our name because we are more and more focused on OTC pharmacy skincare and skin analytics for data-driven skin health management. What began in 2021 with our Efficacy Panel presenting quantitative measurements of product performance in clinical efficacy trials, is a journey leading us to a skintech universe where it is possible to automate dermatological assessment of a skin condition and allow consumers to perform this analysis with their mobile," stated Dr. Barbara Paldus, CEO of Codex Labs.
Codex Labs also announced the launch of an alpha version of its DermScore Skin Analyzer for acne assessment. Consumers can submit a selfie to the www.codexlabscorp.com website where AI software will count comedones, inflammatory lesions, and post inflammatory hyperpigmentation (PIH) spots, as well as assess any existing melasma and freckles. While this software does not replace a trained medical professional, it will enable the consumer to start understanding their skin condition. As a first intervention, the consumer can then schedule a consultation by chat with a licensed esthetician for recommendations. Advice may include finding a licensed dermatologist for professional care and prescription topicals not yet provided by Codex Labs.
"This new AI assessment capability for skin conditions represents a first step towards a more quantified approach to personalized skin management, and a future array of at-home dermatology diagnostic tests," added Paldus. "We look